Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study
Year: 2020
Type: article
Abstract: Fatigue is the most frequent and often debilitating symptom of chronic hepatitis C. It is unclear whether successful therapy of hepatitis C leads to its clinical improvement. In the Virahep-C study, patients with hepatitis C virus (HCV) genotype 1 infection were treated with peginterferon alfa-2a and ribavirin for up to 48 weeks while undergoing assessment of viral kinetics and clinical symptoms.
DOI: 10.17615/1v3f-jn21
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Genentech
OpenAlex ID: W4299394369
